Cite
HARVARD Citation
Fornaro, L. et al. (n.d.). P-147Outcome of second-line chemotherapy (CT2) after first-line CT (CT1) with platinum plus gemcitabine in advanced biliary tract cancer (aBTC): is it worthwhile?. Annals of oncology. p. iv42. [Online].